On the fly News and insights, exclusive to thefly.com

NKE

Nike

$129.00 /

-3.58 (-2.70%)

, CAR

Avis Budget

$76.21 /

-2.04 (-2.61%)

09:58
04/20/21
04/20
09:58
04/20/21
09:58

Fly Intel: Top five analyst downgrades

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Nike (NKE) downgraded to Neutral from Buy at Citi with analyst Paul Lejuez saying he believes in Nike's long-term growth and margin expansion story but he sees near-term pressures due to a slowdown in demand in China related to the Xinjiang cotton issue. 2. Avis Budget (CAR) downgraded to Neutral from Buy at BofA with analyst John Murphy saying he is adjusting his U.S. auto sales and North American auto production forecasts, effectively raising year-over-year growth forecasts for U.S. sales in 2021, but lowering 2022, while simultaneously lowering year-over-year growth forecasts for North American production in 2021, but raising 2022. 3. Clean Energy (CLNE) downgraded to Underperform from Market Perform at Raymond James with analyst Pavel Molchanov citing Clean Energy's announcement that it plans to supply fuel to a modest number of Amazon (AMZN) trucks, the latest instance of sentiment-driven multiple expansion with "minimal read-through" for profitability. 4. Sterling Bancorp (STL) downgraded to Neutral from Buy at Janney Montgomery and B. Riley following the merger with Webster Financial (WBS). 5. Ovid Therapeutics (OVID) downgraded to Neutral from Overweight at Cantor Fitzgerald with analyst Charles Duncan saying the downgrade is driven by a lack of visibility on early-stage programs entering the clinic that would result in value creating events. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

NKE

Nike

$129.00 /

-3.58 (-2.70%)

CAR

Avis Budget

$76.21 /

-2.04 (-2.61%)

CLNE

Clean Energy

$10.92 /

-0.92 (-7.77%)

STL

Sterling Bancorp

$23.64 /

-0.99 (-4.02%)

OVID

Ovid Therapeutics

$3.43 /

-0.28 (-7.55%)

  • 22

    Apr

  • 04

    May

  • 06

    May

  • 26

    May

  • 26

    May

  • 25

    Aug

NKE Nike
$129.00 /

-3.58 (-2.70%)

04/20/21 Citi
Nike downgraded to Neutral from Buy at Citi
03/31/21 HSBC
Nike price target raised to $162 from $158 at HSBC
03/30/21 Oppenheimer
Nike's China issues likely to resolve, says Oppenheimer
03/26/21
Fly Intel: Top five analyst upgrades
CAR Avis Budget
$76.21 /

-2.04 (-2.61%)

04/20/21 BofA
Avis Budget downgraded to Neutral from Buy at BofA
03/16/21
Fly Intel: Top five analyst downgrades
03/16/21 Morgan Stanley
Morgan Stanley downgrades Avis Budget to Equal Weight, sees recovery priced in
03/15/21 Morgan Stanley
Avis Budget downgraded to Equal Weight from Overweight at Morgan Stanley
CLNE Clean Energy
$10.92 /

-0.92 (-7.77%)

04/20/21 Lake Street
Clean Energy deal with Amazon 'a watershed moment,' says Lake Street
04/20/21 Raymond James
Clean Energy downgraded to Underperform from Market Perform at Raymond James
04/20/21 Raymond James
Clean Energy downgraded to Underperform from Market Perform at Raymond James
03/26/21 Cowen
Clean Energy transitions to gas production, Cowen starts with Market Perform
STL Sterling Bancorp
$23.64 /

-0.99 (-4.02%)

04/20/21 B. Riley
Sterling Bancorp downgraded to Neutral from Buy at B. Riley
04/20/21 Maxim
Sterling Bancorp price target raised to $30 from $24 at Maxim
04/20/21 Raymond James
Webster Financial downgraded to Outperform from Strong Buy at Raymond James
04/19/21 Janney Montgomery Scott
Sterling Bancorp downgraded to Neutral from Buy at Janney Montgomery
OVID Ovid Therapeutics
$3.43 /

-0.28 (-7.55%)

04/20/21 Cantor Fitzgerald
Ovid Therapeutics downgraded to Neutral from Overweight at Cantor Fitzgerald
03/04/21 Citi
Ovid Therapeutics price target raised to $5 from $4 at Citi
03/03/21 RBC Capital
Ovid downgraded to Sector Perform at RBC Capital after rally on Takeda deal
03/03/21 RBC Capital
Ovid Therapeutics downgraded to Sector Perform from Outperform at RBC Capital

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.